A Phase II Study of Irinotecan and Taxotere With Concurrent Radiotherapy as a Preoperative Treatment in Resectable Esophageal Cancer.
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Docetaxel; Irinotecan
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 10 Nov 2006 New trial record.